The FDA has made it it’s business to shine a bright light on the evils of illegal fentanyl imports, which are sometimes sold online. That focus seems like it’s a good one. Illegal fentanyl imports get into the hands of drug dealers who use the ingredients to make counterfeit, opioid-based drugs. They sell them to addicts who too often overdose and die. I’ve written a lot about the FDA’s crackdown on illegal fentanyl imports being misused to stop imports of prescription medicines on their way to American patients from Canada and other countries. However, something much more troubling actually has gone down over the past few years.
According to documents obtained through a Freedom of Information Act request by the John’s Hopkins Bloomberg School of Public Health, the FDA ignored information about off-label prescribing of the most dangerous prescription opioid drugs: fast-acting fentanyl or transmucosal immediate release fentanyl (TIRF). Those drugs were approved to treat the most serious pain experienced by cancer patients. Instead, drug companies encouraged off-label prescribing for patients experiencing lower levels of pain and certainly did not have terminal illnesses.
Tagged with: fentanyl, Freedom of Information Act, Obama, The New York Times, trump
Costs of products that improve women’s sex lives by treating a dry vagina, a taboo yet common condition, are on the rise here in the U.S. It’s bad enough to face the unfair stigma of needing medication that has anything to do with your vagina, but Big Pharma has decided to make that experience even more difficult. American women deserve to know that those much-needed products are sold at international online pharmacies for a fraction of the price tag at their local pharmacy.
The New York Times’ Katie Thomas recently published an article, Prices Keep Rising for Drugs Treating Painful Sex in Women, that highlighted this quiet conversation in the corner of the drug prices crisis. Your EpiPens and asthma inhalers are perhaps easier to gripe loudly about than meds related to personal matters. “It’s just infuriating that the price has gone up and up and up for no good reason,” said Cynthia Pearson, the executive director of the National Women’s Health Network, who expressed frustration at the lack of attention due to the stigma.
Women have seen prices on drugs, such as Estrace cream and Estring, more than double in the last five years. The article goes on to report that one woman “has resorted to ordering her drug from overseas at a cost of about $80 for a three-month supply,” which is great news for that savvy lady, but unfortunately leaves the reader hanging on how to safely order their own medication from abroad. After all, shopping for medications online can be quite treacherous: the internet is a landmine of scammers and sellers of counterfeit medication. Peer-reviewed and independent research demonstrates that when consumers use PharmacyChecker-verified pharmacies to buy medications purchased online, they receive lawfully-manufactured, high-quality medication. Not to mention those meds are typically sold at a much lower price than available at local U.S. pharmacies.
Vagifem sold in the U.S., mentioned in the article, is actually manufactured in Denmark. At U.S. pharmacies, just 8 tablets of Vagifem 10 mcg can cost women around $200, but it’s sold at international online pharmacies for as low as $20, a 90% savings. Premarin Vaginal Cream is a whopping 98% cheaper if women order through an online pharmacy in the United Kingdom that’s been verified by PharmacyChecker. Premarin sold in the U.S. is manufactured in Canada.
Vagina may be a stigmatized word, but saving money on meds? Now, that’s something to shout about.
Tagged with: dry vagina, estrace, estradiol, estring, premarin, The New York Times, vagifem, women's health
Today, the New York Times published an Op-Ed by PharmacyChecker.com Vice President Gabriel Levitt entitled “Scare Tactics over Foreign Drugs” which explains that actions by our government and the pharmaceutical industry to frighten people risks leaving them without the medicines they need. I encourage you to read the article.
To learn more about the issues at play check out The International Online Pharmacy Report for 2013: The Good, the Bad, and The Ugly.
Tagged with: Big Pharma, FDA, Gabriel Levitt, The New York Times